HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictive Value of let-7a for Cancer Cell Repopulation between Chemotherapy and Long-Term Survival: A Prospective Study.

AbstractOBJECTIVE:
Repopulation during radiation is a classic theory in radiobiology. The long intervals between cycles of chemotherapy provide better micro-circumstance than radiation for the repopulation of cancer cells.
METHODS:
Patients with inoperable stage III and stage IV lung cancer were enrolled prospectively. Peripheral blood and tumor tissues were obtained before treatment and each cycle of chemotherapy to detect the serum let-7a expression and Ki-67 index.
RESULTS:
Fifty-two consecutive consenting patients were enrolled prospectively. The median follow-up was 13 months (range: 2-62 months). A strong correlation was found between the Ki-67 index and serum let-7a before treatment (r =-0.667, P<0.001). The serum let-7a expression levels were upregulated or downregulated significantly during chemotherapy. Patients with relatively low baseline let-7a expression levels had significantly worse overall survival (OS) and progression-free survival (PFS) than patients with relatively high baseline serum let-7a levels (P<0.001, P=0.005, respectively).
CONCLUSION:
This prospective study demonstrated that let-7a was correlated with tumor proliferation in lung cancer, with high prognostic value. Furthermore, it showed that repopulation, as correlated with let-7a, may exist during chemotherapy, which would give us a new perspective in overcoming the chemoresistance of lung cancer and would help in determining individual treatment strategies.
AuthorsXueqi Xie, Dongdong Du, Yan Guan, Tong Jin, Jinlong Chen, Qian Wang, Dapeng Li, Yinsheng Xie, Naifu Liu, Peng Xie
JournalAnnals of clinical and laboratory science (Ann Clin Lab Sci) Vol. 51 Issue 5 Pg. 638-645 (Sep 2021) ISSN: 1550-8080 [Electronic] United States
PMID34686505 (Publication Type: Journal Article)
Copyright© 2021 by the Association of Clinical Scientists, Inc.
Chemical References
  • Biomarkers, Tumor
  • MicroRNAs
  • mirnlet7 microRNA, human
  • EGFR protein, human
  • ErbB Receptors
Topics
  • Adenocarcinoma of Lung (drug therapy, genetics, mortality, pathology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (blood, genetics)
  • ErbB Receptors (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Lung Neoplasms (drug therapy, genetics, mortality, pathology)
  • Male
  • MicroRNAs (blood, genetics)
  • Middle Aged
  • Mutation
  • Progression-Free Survival
  • Prospective Studies
  • ROC Curve

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: